Novartis (NYSE:NVS) subsidiary Alcon said today that it acquired intraocular lens developer PowerVision for $285 million. PowerVision is developing fluid-based intraocular lens implants that use the eye’s natural accommodating response to transport fluid in the implanted lens, Fort Worth, Texas-based Alcon said. The fluid-based lens creates a continuously variable monofocal lens using the natural contractions of the eye’s […]
Stealthy Atia Medical lands $5m Series B round
Stealthy Atia Medical said it raised $5 million in a Series B round, with the 1st $3 million tranche coming from Medvance Incubator Partners.
PowerVision gains $30 million in funding round | Medtech funding for the week of June 16, 2014
PowerVision raises $30M for FluidVision implantable lens
Ophthalmic devices maker PowerVision finally put a ribbon on its $30 million Series D funding round, planning on using the funds to advance clinical trials in support of regulatory approvals in Europe and the U.S.
PowerVision raises $4M so far in $30M round
PowerVision is trying to fundraise $30 million, having so far brought in $4 million, according to a regulatory filing.
Medtronic, J&J put more skin in PowerVision’s intraocular lens
California-based PowerVision touted another round of fundraising backed by some of the biggest names in medtech.
AirXpanders lands $10M for tissue expansion for breast reconstruction | Funding Roundup
Breast reconstruction technology company AirXpanders Inc. closed a $10 million Series D funding round to support its tissue expansion devices for breast reconstruction.
The Palo Alto, Calif.-based company plans to use the proceeds to advance investigational device exemptions studies, obtain CE Mark approval in Europe and execute market launches in the U.S., Europe and Australia following clearance of its AeroForm system.
PowerVision raises $24 million with a little help from Medtronic
Medtronic Inc. (NYSE:MDT) has signed on as an investor in a $24 million financing round for PowerVision Inc.
The Belmont, Calif.-based PowerVision develops intraocular lenses with a novel technology that uses fluid inside the lens that allows natural forces in the eye to change the lens’ shape and provide better focusing ability.
